https://www.businesswire.com/news/home/20250325183994/en/FORE-Biotherapeutics-to-Present-Two-Plixorafenib-Abstracts-at-the-American-Association-for-Cancer-Research-Annual-Meeting-2025
FORE Biotherapeutics to Present Two Plixorafenib Abstracts at the American Association for Cancer...
FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today announced ...
https://www.businesswire.com/news/home/20260401689895/en/FORE-Biotherapeutics-Receives-Breakthrough-Therapy-Designation-for-Plixorafenib
FORE Biotherapeutics Receives Breakthrough Therapy Designation for Plixorafenib
FORE Biotherapeutics, a registration stage company dedicated to developing targeted therapies to treat patients with cancer, today announced that the U.S. Fo...
forebiotherapeuticsreceivesbreakthroughtherapy